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CHAPTER I
INTRODUCTION

Macrophages play a vital role in the mammalian
host immune response against a multiplicity of invasive
agents including neoplasms (80), bacteria (87), ·protozoa
(86), and fungi (79).

The macrophage is capable of an

extensive range of responses to these agents.

The type

of response is dependent upon the size and type of
target.

Targets such as tumor cells or large micro-

organisms are attacked in an extracellular manner while
most bacteria, yeast, and small protozoans are phagocytosed and destroyed within the macrophage (2).
comparisons of extracellular tumoricidal activity and
intracellular bactericidal activity of macrophages have
been found to be highly dependent upon method of
activation, target type, target state and duration of
the experiment (41).

Different populations of activated

macrophages which have been defined by one functional
criterion do not always possess other functional
characteristics of activated macrophages (130).

This

has been shown in studies where different levels of
macrophage cytocidal activity were observed for extracellular tumor cell killing versus intracellular fungal
1
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(114) or parasite killing (88,95).
The purpose of this investigation has been to
compare the extracellular fungicidal and tumoricidal
activities of four macrophage groups.

The groups were

defined as described previously (82).

These groups of

macrophages were assessed for tumoricidal activity via
release of 5lcr from EL-4 tumor cells and for fungicidal
activity by inhibition of yeast formation following
induction of Candida albicans hyphae.

Both of these

assays measure the ability of macrophages to kill target
cells in an extracellular manner (16,46).

Such a

comparison of extracellular cytocidal activity for both
Candida and tumor cells, by identical groups of macrophages, has not been reported previously. In this study
a correlation has been demonstrated between the acquisition and loss of extracellular tumoricidal and
fungicidal activity by these four groups of macrophages.

CHAPTER II
LITERATURE REVIEW
~.

fungus

albicans, is an opportunistic, dimorphic

commonly found as part of the normal flora of

many mammals, including man.

Diabetes, neoplasms,

immunological defects, and immunosuppressive therapy are
factors which favor the pathogenic invasion of Candida
and the development of systemic infection.

The cellular

immune system is believed to be of vital importance in
the host response to a Candida infection.

As an

example, it is well known that disseminated candidiasis
occurs at a high frequency in patients with chronic
granulomatous disease or myeloperoxidase deficiency.
The antimicrobial capacities of phagocytic cells are
impaired in these patients resulting in increased
infections (69).

Therefore, cells of the phagocytic

lineage are regarded as being critical in the host
defense against systemic candidiasis.

The phagocytic

response occurs despite the fact that invasive lesions
caused by

~.

albicans characteristically contain hyphal

forms which are typically too large to be ingested.

Due

to the large size of these hyphal fragments, phagocytic
cells need to kill through an extracellular mechanism
( 26) •
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Cells of the phagocytic lineage are critical for
host defense against fungi as well as neoplastic cells.
Multiple fungicidal and tumoricidal mechanisms operate
in normal monocytes (2,69). Damage to hyphae has been
largely attributed to products of oxidative metabolism,
although nonoxidative bactericidal activity of monocytes
against Candida has been reported and may be important
in some situations (25).

Additionally, macrophages

serve many roles in the immune response including;
antigen processing, immune regulatory substance section,
and the modulation of immune responsiveness (102).

As a

function of immune responsiveness, macrophages also have
the ability to bind, react with, and kill neoplastic
cells.

This cytocidal event also occurs in an extra-

cellular manner and is potentially mediated by various
macrophage factors.

Tumoricidal effects may be mediated

by either oxidative or non-oxidative mechanisms.
Whether the macrophage killing mechanism for Candida and
neoplastic cells is identical remains unknown and will
be discussed below.
Macrophages are known to possess varying capabilities to respond to stimuli.

These variances in

response to the stimuli are referred to generally as
"activation states" or "levels of activation."

An

evaluation of the comparative extracellular killing
ability of macrophages at various levels of activation
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is the purpose of this study.

A. Macrophage activation
1. Levels of activation.
Macrophages play a major role in a wide variety
of cellular defense mechanisms.

Performance of these

functions requires the simultaneous presence of effective activation signals and competent mononuclear
phagocytes (83).

These functional abilities are not a

constitutive property of all mononuclear cells, rather
such cells acquire these functions in response to
various signals present in the immediate environment
(44).

Furthermore, macrophage-mediated resistance is

localized, short-lived, and only regenerated by reinfection of the host (96).
The monocyte/macrophage maturation sequence can
be divided into four different phases in accordance with
the work of Meltzer: I. Precursor, II. Primed, III.
Triggered, and IV. Postcytolytic (82).

In vivo this

maturation or differentiation sequence occurs in the
following manner:

Phase I: Macrophages which are

recruited and differentiated from immature blood-derived
mononuclear phagocytes into competent lymphokineresponsi ve cells by factors generated at the site of
inflammation.

Phase II: Inflammatory macrophages which

have entered a priming stage in response to immuno-
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modulating factors, during which they are not yet
cytotoxic for infectious agents or tumor cells.

Phase

III: Macrophages which have developed full functional
activity via a triggering signal and are cytotoxic for
infectious agents or tumor cells. Phase IV: Macrophages
which had been functionally active, but have now
returned to a functionally quiescent level.

These

phases of macrophage activation have been also described
as I. Resident, II. Elicited, III. Activated, and IV.
Postcytolytic (82).

Such phases have been characterized

extensively in vitro, and will be discussed further
using this terminology.
I. Resident
Resident macrophages are cells present at any
given site in the absence of an exogenous or inflammatory stimulus (85).

Resident macrophages do not

constitute a stable cellular population, but rather are
constantly renewed by an influx of blood-derived
monocytes and the continuous division of immature
monocytes (125).

Complete turnover of the macrophage

population varies between one and two weeks.

Migration

of circulating monocytes into a tissue site provides for
the majority of new cells, since dividing cells account
for only 35% of the total cellular population (22).
II. Elicited
The term, "elicited", indicates an accumulation

7

of exudate macrophages at a particular site.

Elicited

macrophages are attracted to a given site by certain
stimuli.

Investigations of in vitro macrophage acti-

vation have normally been carried out with macrophages
obtained 3-4 days after induction of inflammation in the
peritoneal cavity (65).

These cells are a heterogenous

population composed of resident macrophages and those
macrophages derived from emigrating blood monocytes
responding to the inflammatory stimulus (22).

Such

induction also results in the accumulation of other cell
types, such as lymphocytes, which have the potential for
modulating the functional activity of macrophages.
III. Activated
The term "activated" macrophage was originally
coined by Mackaness to define the enhanced non-specific
resistance to intracellular bacteria observed in animals
recovering from infection with Listeria monocytogenes
(125).

Activated macrophages are cells with increased

functional activity induced by a given stimulus which
either increases one or more of the functional activities of the cell or induces a new functional cellular
activity.

The process of macrophage activation is not

the result of a single interaction between the signal
and cell, but appears to be the final step of an
activation process which requires a defined progressive
sequence of reactions for complete cellular activation
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(82,83,105).
IV. Postcytolytic
Macrophages which have been activated for a
prolonged period of time lose their cytocidal capabilities.

These macrophages have been maximally stimulated

previously and have returned to a normal or resident
level of cytocidal activity.

These cells are in a

terminal maturation stage, yet still maintain responsiveness to proper stimuli, and can return to a cytocidal
state (82).
The pathway of macrophage differentiation leading
to the acquisition of nonspecific tumoricidal capability
proceeds along a continuum from the unaltered resident,
to the activated macrophage, returning to a noncytolytic
cell (128).

Accordingly, macrophages have adapted the

ability to become directly responsive to microbes, and
to molecules arising from microbial degradation (75).
In addition, macrophages are responsive to lymphokines
produced by other cellular defense mechanisms (35).

The

ability to respond in this manner is an evolutionary
advantage which allows the macrophage to react in a
varied context to different stimuli (68).
The induction of macrophage cytotoxic reactions
by any of several different primary activation signals
is regulated (either amplified or suppressed) in turn by
a variety of unrelated secondary signals (81).

There-
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fore, not only can macrophages enhance their overall
functional potential but also they can provide a
selection of different functions.
capable of individual enhancement.

Each of these is
This individual

enhancement usually leads to concomitant suppression of
other functions (2).
Differences in macrophage response to activation
signals are not necessarily related to the number of
activation signal receptors present on a given cell
(81).

A resident macrophage may be more, less or

equally responsive than an elicited cell to an activation signal.

The responsiveness of the cell depends

directly on the stimulus and state of the elicited cell
(81).

The ability of macrophages cultured in vitro to

respond to activation signals and kill neoplastic or
microbial targets changes with time in in vitro cell
culture (81).

Macrophages cultured in medium prior to

addition of lymphokines, gradually lose the capacity to
be activated (83).

It is believed that the immature

monocyte is responsive to stimuli for only a short
period of time.

The lack of responsiveness may account

for the progressive decrease in cytotoxic activity of
macrophages cultured for days in vitro (83).
The cytocidal state of macrophages is mediated by
specific signals such as lymphokines and lipopolysaccharide (LPS) but not by nonspecific inflammatory
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stimuli such as thioglycollate (93).

An increase in

certain functions associated with the elicited macrophage, such as phenotypic markers or secretory proteins,
are not accompanied always by an enhancement in bactericidal activity (117).

Elicited macrophages have been

shown to possess different bactericidal activities
(109).

Likewise, the types of macrophages which are

elicited may also vary.

The thioglycollate-elictied

macrophage response is dependent upon the age of the
mouse from which the cells were derived.

Thioglycollate

can recruit macrophages drawn from a pool of older
preformed monocytes or macrophages (54).

These thio-

glycollate-elicited macrophages phagocytose more
bacteria and therefore provide a more efficient cell for
potential intracellular microbial growth (85).

These

cells have been shown to have lowered listericidal
activity (117), suggesting that thioglycollate may
impair antimicrobial activity (54).

Furthermore, the

responsiveness of elicitec macrophages may be modulated
by endogenous microorganisms and/or microbial products
(75).

Therefore, the environment of the host may

contribute to observed fluctuations in certain experimental systems following thioglycollate elicitation
(68).

Some controversy exists as to the ability of
thioglycollate macrophages to kill both tumor cells and
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microbial targets (61).

Furthermore, the ability of

thioglycollate-elicited macrophages to be further
activated to cytocidal states has been debated (96).
Nathan (93) has found that peritoneal macrophages can be
activated by LPS equally well whether they are resident
or elicited.

Other studies have found thioglycollate-

elicited macrophages to kill very well and to be further
activated to cytocidal activity by LPS (31).

Still

other investigators have found thioglycollate-elicited
macrophages to lack cytocidal ability for a variety of
targets (11,61).

These discrepancies may be attributed

to the agar contained within macrophages elicited with
thioglycollate (32) and the interference by agar in
macrophage metabolism (31).

Despite comparable glycogen

content, resident macrophages take up glucose while
thioglycollate-elicited macrophages do not, suggesting
metabolic alteration resulting from agar uptake (31).
Finally, macrophage properties relegated to nonspecific
inflammatory influences may be rapidly bypassed by
lymphokines which induce a microbicidal macrophage fully
capable of functional activity.
Macrophage precursors are induced by colony
stimulating factors (CSF) to proliferate and differentiate into macrophages.

Under defined in vitro

conditions, a resident macrophage arises from the
progenitor cell (39).

Macrophages derived from bone
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marrow and treated with lymphokines or LPS induce
similar maturation changes to that of resident macrophages being activated (53).

However, activated bone

marrow macrophages mediated ten times the tumoricidal
activity of resident macrophages, while maintaining the
cytocidal effect for a longer period of time (7).

CSF

has been shown to induce distinct morphological and
metabolic alterations in resident macrophages.

These

modifications are clearly distinct from those induced
with gamma interferon and appear to affect all cells of
the culture (7).

CSF also affects mature macrophage

functions and metabolism resulting in an increase in
RNA, DNA, and cell size along with synthesis and
secretion of a variety of substances such as PGE2,
interleukin-1, and proteases (7).
2. Regulation of activation
Despite the nonspecific manner in which activated
macrophages express their cytotoxic effects, the
sequence of events leading to the activated state
require precise interaction of macrophages and appropriate stimuli (66).

Resident macrophages can be

induced to the priming stage by lymphokines.

But,

another trigger, such as LPS, is required before
macrophages become fully activated (105).

Several

groups have found full cytotoxic activity is best
obtained when LPS and a lymphokine, such as gamma
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interferon (100), are synergistically combined (99,128).
Priming or triggering of macrophages by LPS occurs at
concentrations as low as 0.1 ng/ml, and increases in a
dose-dependent manner (103).

The period of macrophage

activation and/or responsiveness is short-lived (83,105).

In vitro macrophage activation to a tumor-

icidal state, in vitro by LPS has been shown to appear
as early as 4 hours following stimulation.
responsiveness is apparent for 6-16
by 36 hours (75,105).

Maximal

hours and is lost

similar observations have been

made in vivo where macrophages have been shown to lose
their cytotoxic capacity quickly following an antigenic
challenge (83).

This decrease in cytotoxic activity is

irreversible, but is not a consequence of changes in
cell viability.

Rather, it is the result of terminal

maturation and differentiation of the cell population
(82).
It has been proposed by Pace and Russell that the
role of the lymphokine is not to effect full activation
but rather to increase macrophage sensitivity to the
effects of LPS (99).

Lymphokines acting alone, without

LPS, fail to activate macrophages to cytocidal activity
(99).

Conversely, LPS has been shown by Weinberg to act

as a signal for activation of macrophages in the absence
of lymphocytes or their products (128). Furthermore,
high doses (µg/ml) of LPS can activate an elicited
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population of macrophages completely to both inhibit
cell proliferation and provide a cytotoxic response
without a requirement for lymphokines (75).
The mechanism by which LPS modifies macrophage
responsiveness is unclear, but it is likely that it
initially acts at the level of the macrophage plasma
membrane (128).

LPS has been shown to associate both

with artificial (12) and biological (64) membranes.
Evidence exists that LPS interacts with cell membranes
by associating with the plasma membrane, intercalating
in the phospholipid bilayer, after which it is endocytosed by the cell (60). These data suggest that
modification of the macrophage membrane alter cytocidal
capacities (124).

Therefore, the insertion of LPS into

the membrane and the perturbation of the membrane
results in macrophage activation by transmitting the
necessary signals from the membrane to the vacuolar
system {60,124).
is unknown.

The molecular basis of this phenomena

However, addition of LPS alters the

cellular protein composition of the macrophage which
then allows it to become functionally competent (44).
There are several other major modifications of
the macrophage membrane during the process of activation.

Lipid composition correlates specifically with

development of tumoricidal activity.

Total lipid

content of tumoricidal macrophages is far greater than
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that of noncytolytic macrophages (109).

Loss of

tumoricidal activity directly parallels the loss of
esterified cholesterol, suggesting that the macrophage
activation process may be modulated by cellular lipid
content (109).

A high-molecular-weight serum lipo-

protein is responsible for modulation of macrophage
cholesterol content (109).

Macrophage activation to the

tumoricidal state has also been shown to be calcium
dependent (131).

Calcium ionophore A23187 enhances

secretion of a cytolytic factor from macrophages, while
calcium channel blockers inhibit activation (131).

This

suggests calcium channel activity is linked with the
biochemical reactions for devolvement and expression of
macrophage functional activity.

The release of the

ionophore changes phosphoinositol lipid metabolism which
results in the mobilization of calcium ions following
activation (131).
According to Drysdale et al. there exists two
pathways by which macrophages may be activated (28).
The first, is unaffected by the prostaglandin (PG)
synthesis inhibitor, indomethacin.

The second, is

inhibited by indomethacin and is a consequence of
activation by LPS or lymphokines (28).

Low levels of

PGEl or PGE2 will restore cytocidal activity in nonactivated cells cultured in vitro (84).

But, PGE2

inhibits macrophage activation as a negative feedback
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signal, preventing nonspecific spreading of a cytocidal
effect (110).

Conditions which favor high PGE meta-

bolism result in the activation of resident and elicited
macrophages while inhibiting activated macrophages
(111).

PGE2 accumulation in macrophage culture media

has been claimed to be responsible for the concomittent
loss of macrophage-mediated tumoricidal activity.
Resident and elicited macrophages however, become
tumoricidal when pretreated with PGE (111).

The

mechanism does not prevent the development of macrophage
mediated cytolytic activity, but rather shuts it off
once it develops full cytotoxic potential.

Cultures

treated with indomethacin sustain high levels of killing
for long periods of time (120).

Therefore, prostagland-

ins have differential effects on macrophage antitumor
activity depending upon the prior activation state of
the macrophage (120).
Additionally, other suppressive accessory factors
can be derived from endogenous and exogenous sources
(81).

Several studies have shown that tumor cell

culture supernatants, tumor extracts, and sera from
tumor-bearing animals possess suppressive properties for
macrophages (60). Some neoplasms themselves contain
increased amounts of PGs.

As one example, factors

released from the EL-4 cell line can suppress macrophage
cytocidal activity against all microbial targets tested,
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yet only

selectively inhibit tumoricidal activity (81).

Furthermore, suppression of the macrophage is limited to
the site of the tumor (120), and products of activated
macrophages that are normally associated with cytocidal
activity have been implicated as possible mediators of
the suppression (84).
3. Biochemical and functional capacities of macrophages
The process of macrophage activation results in
extensive but selective alterations in macrophage
properties (39).

Resident, elicited, and activated

mouse macrophages display marked phenotypic heterogeneity along with selective surface, secretory and
endocytotic differences (39).

This heterogeneity is

observed consistently among these populations regardless
of the site from which the macrophages were isolated
( 3 9) •

Microscopically, the most salient feature of the
activated macrophage is the larger size which is
expressed as a result of increased protein content (22).
Macrophages secrete in excess of 50 different proteins
(54).

The secretion of these proteins depends both on

the physiological state and activation level of the
macrophage (54).

The age and origin of the macrophage

is very important as well, since secretion profiles are
modified upon maturation and differentiation (54).

Many

proteins are constitutively produced by macrophages at
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all activation levels (54), and products unique to
activated macrophages represent less than 8% of their
total secretory activity.
Several groups of investigators have attempted to
correlate various macrophage maturation markers (appearance of receptors, either biochemical or physiological)
to distinct stages of activation.

This work has proven

difficult to interpret due to the variable nature of
activation mechanisms utilized.

However, several

characteristics of macrophages at different levels of
activation appear to be consistently observed.

(See

Table 1).
Macrophages which have been induced to the primed
stage, share some, but not all of the properties common
to activated cells (2).

Activated and induced macro-

phages show an enhanced oxidative response to stimuli,
relative to resident macrophages (63). Resident macrophages which functionally present some similarities to
neutrophils, posses an efficient intracellular microbicidal activity but are less actively fungicidal than
neutrophils (25).

Additionally, resident macrophages

generally lack the ability to kill extracellular
pathogenic fungi (14).

B. cytocidal capacities of macrophages
1. Candidacidal capacities
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Table 1. summary of Macrophage Characteristics
Level of activation

Macrophage
characteristic

Intracellular enzymes
Lysosomal hydrolases
Alkaline phosphodiesterase
B-galactosidase
Surf ace receptors
Fe
Complement
Man-GlcNac
Ia
5 1 -Nucleotidase
CSF-1
Secretory capacities
Lysozyme
Neutral proteases
ROI release

I

II

III

(ref)

+

++

+++

2

+
+++

+++
+

30

+++

++
+
+
+
+/+++

+++
+
+
+++

95

+

39

++

++
+++

15

+
+
+

+++
+++

++

++
+++

111

+
+
+
+

+++
+++
+++

52

++
++
++

+++
+++
+++
+++
+++

54

+
+++
+++

+/+++
+++

++
+

02H202

Arachidonic acid
metabolites
Complement
Monokines
IL-1
TNF
cytotoxins
Cellular characteristics
Cell protein
Spreading
o2 uptake
Glucose uptake
Phagocytosis
Cytocidal capacities
Bind tumor
Kill tumor
Kill intracellular
organisms
Kill extracellular
organisms

+++

+

+
+

+

++
+
++

+

75

34

112
112
30

4
62

115
34

38

61

29

112
75
29

+

+++
+++

61
61

++

+++

92

+

+++

122

I, II, III, = Levels of activation. Incomplete data on
level IV. -, +, ++, +++, = Relative levels of activity.
+/- = Disputed, absent versus low levels.
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Invasive Candida albicans infections normally
result in hyphal forms which are too large to be
phagocytized (25).

Early work by Diamond demonstrated

that PMNs could damage and kill

~.

albicans through non-

phagocytic means by adhering directly to the hyphae
(56).

Similarly, studies of macrophage-Candida inter-

actions have resulted in the same finding (26).
Macrophages have a large and diverse arsenal with which
to combat infectious agents.

This is generally divided

into two classifications 1) oxygen-dependent and 2)
oxygen-independent.

Reactive oxygen metabolites are

responsible for much of the microbicidal (63) activity
of macrophages, although killing by oxygen-independent
mechanisms also occurs (72).
Oxygen-dependent systems are classified as such
due to a decrease in microbicidal activity under
anaerobic conditions (115).

The generation and secre-

tion of reactive oxygen intermediates (ROI) is the end
result of a coordinated sequence of metabolic events
termed the respiratory burst.

This function is not

constitutive, but must be acquired.

Acquisition of

competence to execute the respiratory burst involves
modulation of the cellular and biochemical elements
necessary for the production of ROI (62).

Agents which

activate macrophages alter the expression of cell
surface receptors.

The altered receptors then trigger

21

the respiratory burst (62).

The respiratory burst can

be modulated at a number of different mechanistic
levels.

These include; the amount and/or function of

cell surface receptors, the amount and/or function of
enzyme systems which generate the output, and the
various elements which couple these two systems (2).
All either directly or indirectly stimulate protein
kinase c (PKC), suggesting PKC is a central element in
stimulus-response coupling for the respiratory burst and
secretion of ROI (62).
The value of ROI in defense against Candida
infection has been elucidated in studies of cells from
patients with chronic granulomas disease and hereditary
myeloperoxidase deficiencies (69).

These along with

studies utilizing ROI scavengers have shown that ROI
(superoxide, hydrogen peroxide, singlet oxygen, and
hydroxyl-free radicals) produced by the respiratory
burst, all act in concert to mediate hyphal destruction
(25).

For example, superoxide (o 2-) itself does not

directly damage hyphae, but serves primarily as an
intermediate in H2 o2 production important to the
myeloperoxidase-halide system (26).

However, iodination

has been shown to not be essential for myeloperoxidasemedia ted killing but is a non-casual sidelight of the
candidacidal activity of macrophages (69).

The candid-

acidal effects of singlet oxygen can be diminished by
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quenching agents, such as histidine, suggesting a
possible role for the molecule in hyphal destruction
(26).

Additionally, activated macrophages have been

shown to produce high amounts of o 2 - in vivo and
therefore may protect the host against Candida infections (23).

Hyphal damage appears to result from

products of oxidative metabolism, especially the
myeloperoxidase-H 2 o2 -halide system, but myeloperoxidaseindependent mechanisms are active as well (26).
Furthermore, anaerobiosis significantly reduced, but did
not eliminate, damage to hyphae by macrophages indicating at least some oxygen-independent mechanisms may be
involved in target cell destruction (26).
Macrophages possess a variety of hydrolytic
enzymes which function in an oxygen-independent manner
(23). These fungicidal constituents, such as B-glucosaminidase, are found within macrophage cytoplasmic
granules such as lysosomes (69).

Lysosomal constituents

have been shown to be released by macrophages following
contact with target cells and to be microbicidal (2,24).
Two microbicidal cationic peptides (MCP-1 and MCP-2)
produced by rabbit alveolar macrophages have been found
by Patterson-Delafield §.t al. These peptides are
effective against diverse gram positive and negative
bacteria and fungi, and act either extracellularly or
within the phagolysozome (73).

These proteins, rich in
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arginine and cystine, are distinct from histones and
have been found to suppress cellular oxygen consumption
by Candida (72).

In studies using partially purified

fractions of macrophages enriched for lysosomal granules
Candida hyphae where not damaged (26).

These results

suggest that cationic proteins and perhaps other granule
constituents might act as ancillary antifungal mechanisms, enhancing effects of oxidative mechanisms (97).
Despite findings that suggest a role for oxygen-dependent and oxygen-independent mechanisms for Candida
killing, it remains unclear which intermediates or
pathways are directly responsible for hyphal damage
(25). Conflicting data regarding the ability of in vitro
cultured macrophages to destroy
reported.

~.

albicans

has been

The disparity in results is a consequence of

the utilization of mononuclear cells derived from:
various sites, such as the blood (69), the peritoneum
(23) or the alveoli (71); from various animal species,
including mouse (62), man (69), and rabbit (71); as well
as elicitation of the cellular populations with various
in vivo adjuvants (51).

Analysis is further complicated

by the use of monocytes (69) or resident (63), induced
(51), lipopolysaccharide (LPS)-activated (71), or
lymphokine-activated (14) macrophages.

Furthermore,

many studies have used the capacity for intracellular
killing of ingested yeasts to determine candidacidal
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activity.

This may not reflect the ability of the

macrophage to damage hyphae at the cell surface by
nonphagocytic mechanisms (26).

such a non-standardized

approach has made comparisons of macrophage activity
difficult.
It is known that contact between the macrophage
and hyphae cell is vital for destruction of fungi in
macrophages (37).

Electron micrographs of monocyte-

Candida interactions have shown monocyte plasma membranes adhering directly to portions of hyphal cell
walls.

Sections of hyphae in contact with the macro-

phage were partially engulfed, damaged and disrupted
(26).

This hyphal damage was accompanied by damage to

the monocyte itself, in that many hyphae had surfaceadherent vesicles that were bounded by three-layer unit
membranes (26).

These studies did utilize peripheral

blood monocytes and the lability of human monocytes
compared with mature macrophages has been shown to be
significant (19).
During infections, yeast forms of Candida are
found in tissue, although the prevalent form is the
hyphal stage (11) •

It has been suggested that hyphal

forms of Candida are endowed with in vivo resistance to
host phagocytic defenses via a variety of mechanisms
(107).

Adherence of macrophages to the hyphae has been

shown to occur through a cell wall constituent, most
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probably mannose, which then stimulates the respiratory
burst (24).

The release of this soluble material has

been shown to then inhibit further macrophage activation
resulting in suppression of macrophage function (90).
Degradation by phagocytic cells, results in the reduction of target cell cytoplasm.

Cell wall deformation

and collapse are all a result of enzymatic breakdown of
Candida cell wall mannan by macrophages (37). The most
invasive adaptation of Candida is the ability to
alternate between the yeast and hyphal forms during its
multiplication.

This has been related to its ability to

evade host defenses (101).

The transition between the

two stages appears to be important in the expression of
fungal pathogenicity, although no definitive evidence
exists which compares relative pathogenicity with
different morphologies. Possibly cell wall composition
and architecture of the two forms under different
conditions may force Candida toward morphological
transition (70).
2. Tumoricidal capacities
Vital roles have been proposed for cellular
immunity in the complex host reaction to neoplastic
disease (47,102).

Killing of tumor cells, at least in

vitro, can be mediated by many different cell types.
The tumoricidal activity of macrophages has been the
object of a great deal of study.

Mackannas defined
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activation as: the enhancement, through immunologically
specific reactions, of the immunologically non-specific
capacity of macrophages to kill microbial pathogens
(90).

However, activation is often defined as the

capacity of macrophages to mediate cytotoxicity towards
tumor cells.

Whether macrophages kill tumor cells in

vivo as a mechanism of primary defense is still unknown.
However, in vitro nearly all tumors are susceptible to
macrophage cytotoxicity in a nonphagocytic, contactdependent process (90). The interaction between activated macrophages and target cells often leads to
selective destruction of the neoplastic cell. It has
been shown in vitro that layers of tumor cells will grow
adjacent to but not in areas of macrophage growth,
suggesting that cytolysis is restricted to the immediate
vicinity of the macrophage (32,45,49). The mechanisms of
tumor cell destruction by macrophages have been studied
extensively (36,49), and may be affected by many types
of secreted products such as enzymes, reactive oxygen
intermediates, and secretory products.
ROI are responsible for a great deal of candidacidal activity, however, the tumoricidal activity of
ROI is not completely understood.

Nathan has suggested

that an oxidative mechanism may provide the means by
which activated macrophages kill tumor cells (92).
There is some evidence H202 is tumoricidal in vitro
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(92).

A possible role for myeloperoxidase in the

killing of tumor cells by macrophages has also been
suggested (18,104).

However, it has been found that

induction of tumoricidal function does not correlate
with induction of the respiratory burst either as a
matter of time or stage of macrophage activation (21) .
Additionally, a majority of macrophage tumoricidal
effects have been assigned to oxygen-independent
mechanisms despite the observation that the toxic
effects of macrophages toward target cells were significantly reduced when cells were cultured under anaerobic
conditions (115).
Extracellular secretion of proteins has been
established as an important function of macrophages,
suggesting the possibility that tumor cells may be
destroyed by secreted products (2). Although primarily
cytotoxic, these agents may serve to digest infectious
agents which were killed by predominantly oxidative
mechanisms (66).

Possible mediators of macrophage

oxygen-independent cytocidal activity include: acid
hydrolases (2); alkaline phosphatase (30); arginase (4);
and neutral proteases (1).

Such secreted factors may

play an important role in infectious agent destruction
since killing of tumor cells normally precedes the
degradative and destructive processes of phagocytosis
( 2) •
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Even in the absence of phagocytosis it is still
possible that macrophages may transfer their lysosomal
enzymes by a process of exocytosis (15).

It has been

shown that the content of secondary lysosomes are
transferred to the tumor cell prior to cell lysis (48).
Furthermore, it is known that lysosomal enzymes of
activated macrophages mediate tumoricidal effects (48).
The macrophage-tumor cell interaction is initiated by a
recognition phase that results in polarization and
eventual release of lysosomal constituents through
macrophage exocytosis and membrane fusion (41).
Lysosomes are transferred from activated macrophage to
the cytoplasm of target cells (48,36).

Biochemical

changes which have been detected in the cell surface
membrane of activated macrophages (e.g. 5'-nucleotidase)
are similar to changes detected in the membranes of the
phagosomes (66).

Perhaps these or similar membrane

changes are related to the capacity of the lysosomal
membrane to fuse with the cell surface membrane prior to
lysosomal exocytosis (35).
Macrophages also secrete multiple components of
the complement system, including constituents of both
the classic and alternative pathways (2).

Macrophage-

produced C3 can be cleaved into C3b, which activates
macrophages to secrete hydrolytic enzymes, and C3a which
is lytic for tumor cells (34).
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Tumor necrosis factor (TNF) is a soluble molecule
which may be involved in macrophage tumor cell killing
(123).

TNF is

produced almost immediately following

exposure to LPS and its production is dependent upon the
continued presence of LPS (38). Exposure of macrophages
to LPS results in the production of TNF (38).
itself is capable of lysing targets.

TNF

Lymphotoxins or

lymphocyte cytotoxic factors, are another set of
macrophage cytotoxic products, which also directly lyse
neoplastic cells (124).

Lymphotoxins may be very

similar or identical to TNF since studies have found
that an anti-TNF antibody also removes the cytocidal
activity of lymphotoxin (132).

However, in short term

assays only TNF is effective in tumor cell lysis,
whereas both TNF and lymphotoxin are effective in long
term assays (132).

Many investigators appear to have

isolated different cytotoxic factors.

For example,

different cytotoxic factors found in serum have different stabilities at room temperature (122) and cytotoxic
factors have varying sensitivity to heat treatments and
proteases (124).

One cytotoxic factor secreted from a

macrophage hybridoma appears to be distinct from all
other cytotoxic factors since it is heat stable and acid
labile while others are not (121).

Additionally,

macrophage hybridomas have been produced which secrete
cytotoxic factors and Interleukin-1 (IL-1) (122).
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During infection, macrophages with bactericidal and
tumoricidal activity display a parallel increase in IL-1
and cytotoxic factor production (52).
IL-1 is a central mediator in the regulation of
the immune response.

Macrophages are a major source of

IL-1 and release it during the activation process.
Regulation of IL-1 is itself complex.

Low levels of TNF

induce increased IL-1 production, while the converse is
also true (52).

However, these two are not direct

mediators of one another, as high TNF levels induce PGE
which blocks IL-1 production (52).
The sensitivity of tumor cell lines to macrophage
tumoricidal effects varies greatly and some tumor cells
are even promoted to proliferation by macrophages (93).
Completion of tumor cell lysis by macrophages requires
direct binding to target cells (109).

However, the

glutathione oxidation-reduction cycle serves as a
mechanism against oxidant injury, and accounts for
varying susceptibility of tumor cells to oxidation (91).

The sequence of events for macrophage killing of
tumor cells may then be summarized in the following way:
a)contact occurs between macrophages and target cells;
b) lysosomal enzymes of macrophages are polarized toward
bound tumor cells; c) spreading of macrophages at the
tumor cell surface occurs; d) oxidative mechanisms are
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released which weaken the tumor cell membrane; e)
lysosomal constituents are released and tumor cells are
lysed (2).

c. Comparisons of extracellular killing
It has yet to be determined whether increased
tumoricidal and increased microbicidal activity are
always generated together as a consequence of the
activation process (96) •

Some evidence exists which

suggests that the two activities are separate (130).
The possibility exists that macrophage activation occurs
in a series of definite steps.

This is indicated by the

presence of one manifestation of activation occurring in
the absence of others.

The number of activation steps

may be determined by the particular homeostatic functions which the macrophage perform (96).

For instance

synthesis and secretion of plasminogen may require a
definitive number of steps.

Metabolic changes required

for this action may occur earlier than or without
acquisition and expression of the more complex function
of increased microbicidal or tumoricidal activity (96).
Whether populations of activated macrophages
which display one functional activity also possess other
functional capacities is not established (130) •
Experiments have been conducted to measure the ability
of macrophages to inhibit tumor cell DNA synthesis and
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intracellular multiplication of Toxoplasma gondii (130).
Macrophages removed from Toxoplasma spiralis infected
animals after 19 weeks were able to inhibit tumor cell
DNA synthesis yet were unable to prevent intracellular
multiplication of T· gondii (130).

Macrophages taken

from the animals infected with T· gondii at 16 weeks and
used immediately, inhibited DNA synthesis of tumor cells
but failed to inhibit T· gondii intracellular replication (130).

However, following incubation for 24 h

in

vitro, the capacity of these same 16 week macrophages to
inhibit tumor cell DNA synthesis was lost while T·
qondii intracellular replication was inhibited (130).
These results suggest that the functions of activated
macrophages in a given population maybe identical at any
given time.

However, the time of infection, the

elicitation agent or immunization agent, and the time in
culture, may alter the observed functional capacities of
any given macrophage population.
The functional differences in different macrophage populations which were observed by Wing (130) have
also been observed by many other groups.

Macrophages

which express specific antitumor activity, or express
antibacterial resistance, did not kill the intracellular
organism Listeria (130).

Therefore there is a clear

dissociation of intracellular microbicidal activity from
other macrophage functions (95,114).

Conversely, it has
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also been shown that host responses to intracellular
infect:on results in an increased resistance to neoplasia (125).

It Las been proposed that at maximum

stimulation, all functional properties of activated
macrophages may be expressed (130).

The properties

might be lost at different rates and consequently, at
various times after activation only certain properties
of activated macrophages are manifest.

The functions of

a given population must be considered with the number of
factors already discussed which may induce variance
(130).

Alternatively, there may exist separate subpopu-

lations of macrophages which are activated differentially and posses distinct functional capabilities
(130).
Mature macrophages from different sites may
differ functionally depending on which function the
macrophage is called upon to perform.
functions is the ability to kill.

One of these

This functional

heterogeneity in macrophage lineage is detectable at the
precursor level (10).

Bone marrow-derived macrophage

precursors from CSF conditioned cultures possess the
ability to kill, extracellularly, YAC-1, Candida
albicans, and Leishmania (10).

These nonadherent,

nonphagocytic, macrophage precursors originate from 3
day bone marrow liquid cultures.

These cells are

normally located in the bone marrow prior to recruitment
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to peripheral organs (9).

These macrophage precursors

have been proven to possess an overall candidacidal
potential greater than that expressed by resident
macrophages (8).

The same cells are also active against

YAC-1 lymphoma cells (8).
Bone marrow-derived macrophage precursors are
able to mediate extracellular killing against tumor and
fungi targets (8).

Both of these activities are lost

during the course of maturation to mature macrophages
only to be regained later (8).

For example, bone

marrow-derived precursors can differentiate in the
presence of CSF-1 which is deficient in interferon {IFN)
to become resident macrophages.

These mature bone

marrow derived-macrophages are unable to kill Candida
{8).

The same cells when exposed to CSF-1 and IFN, can

progress developmentally to a more differentiated state
which has the capacity to kill {127).

Upon activation,

restoration of the cytocidal activity resumes in a
process analogous to that observed for macrophages
infiltrating an inflammatory site (127). The common
precursors seem to lose or retain their activity
depending on the environment of the anatomical site into
which they migrate (8).
Despite common mechanisms for the induction and
expression of macrophage effector responses within the
transient cytotoxic reaction, separate signals may
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activate different functional capacities (89).

Studies

by Nacy (89), have shown that lymphokines from stimulated spleen cells regulate cytotoxic reactions against
various targets through different activation factors or
lymphokines.

For instance factors added from cultures

of murine spleen cells induce microbicidal activities
against the intracellular targets

Rickettsia tsu-

tsugamushi or Leishmania tropica.

These same factors

are completely ineffective for inducing cytocidal
activity against extracellular targets such as tumor
cells or Schistosoma mansoni (89).

Furthermore,

lymphokines which induce intracellular killing can be
separated into three components or factors.

The

extracellular killing is induced by only one factor,
separate from the factors which induce intracellular
killing (89).

If a population of the T-cell lymphoma

EL-4FARRAR is stimulated with PMA, extracellular killing
and intracellular killing were found to be exclusive
(89).

In this situation, lymphokines were found to

contain two components which induced extracellular
killing, whereas only one lymphokine component was found
to induce intracellular killing.

The component which

induced intracellular killing appeared to be identical
to one of the extracellular components (89).

These data

suggest that induction of an effector response is
dependent upon specific activation factors. It is clear
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that macrophage activation for cytotoxicity against
tumor and schistosomula targets is coincident over a
broad range of experimental conditions (59).

Both

resident and elicited macrophages can be activated to
this parallel activity (59).

Whether the mechanisms of

macrophage cytocidal tumoricidal and schistosomulacidal
activity induced by these lymphokines are similar
remains to be clarified (58).

Both cytocidal activities

were induced by the same large molecular weight activating factors suggesting that identical effector function
originates from the same activating signal (89).
identiy of these lymphokines is unknown.

The

Whether the

lymphokine activities are from unrelated molecules or
aggregates of a single molecule also is unknown. What is
most important is that macrophage cytocidal activity
against two divergent extracellular targets, tumor cells
and helminthic worms were induced by the same macrophage
activating lymphokines (89).

Equally important was the

observation that cytocidal activity against two totally
unrelated intracellular parasites that reside in
different compartments (intracytoplasmic rickettsiae and
intraphagolysosomal leishmania) was induced by a common
mechanism (89).

The extracellular cryptococidal and

tumoricidal results of Granger closely parallel the
cytostatic effects noted above (42).

In fact, the

kinetics of onset and the effector cell sensitivity to
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LPS, again indicate a similar mechanism of activation
( 4 2) •

It appears clear that regulation of macrophage
cytotoxicity is controlled by qualitatively different
factors (89) .

One which controls extracellular targets,

another, which controls intracellular cytotoxicity (89).
The cytocidal activities of macrophages are
influenced by many factors, including the level of
activation of the macrophage.

The capacity of macro-

phages to respond to stimuli and induce a functional
response, such as extracellular killing, has been
studied extensively (89).

In comparisons of extra-

cellular killing of schistosomes and tumor cells,
cytocidal effects were found to take place upon activation with particular lyrnphokines (90).

The activation

of macrophages with LPS has shown similar results.
Nonactivated states, (resident and elicited) displayed
parallel tumoricidal and schistosomicidal activity,
again emphasizing similar levels of activation for
extracellular cytocidal activity.
In contrast, little work has been done

c~mparing

the candidacidal and tumoricidal effects of macrophages.
Most studies of Candida have been performed with the
yeast phase of the fungus which is phagocytosed and
killed in an intracellular manner (108).

Based on

studies by Nacy et .sU:.., comparing differential activa-
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tion of macrophages by certain activating factors for
intracellular cytocidal activity as compared to activating factors which induce extracellular cytocidal
activity (89), one would not expect to find similar
levels of activity for the intracellular killing of
phagocytozed Candida as compared to the extracellular
killing of tumor cells.

Instead it would be expected

that the intracellular killing of phagocytosed Candida
would be mediated by different activation mechanisms and
different cytocidal mechanisms than that of the hyphal
form of Candida which must be killed in an extracellular
manner.

The possibility exists that similar activation

mechanisms for cytocidal activity would be demonstrated.
However based on the wide differences encountered by the
macrophages in comparing these two targets the possibility is unlikely.

More likely is a separate and distinct

activation mechanism for extracellular killing and
intracellular killing.
Work on macrophage precursors has indicated that,
in a nonphagocytic manner, these cells have the ability
to kill Candida, Leishmania, and tumor cells.

That

study utilized the yeast phase of Candida, relying on
the inability of the macrophage precursor to phagocytize
for studies of extracellular killing (8) rather than
studying the mature macrophage and its extracellular
killing mechanisms.
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No studies have been completed comparing the
cytocidal effects of macrophages on Candida in the
hyphal form to the cytocidal effects of macrophages on
tumor cells.

Furthermore, no study has been undertaken

to evaluate the relative cytocidal capacities of
macrophages at various levels of activation.

This study

compares the levels of candidacidal and tumoricidal
activity of macrophages at set levels of activation.

CHAPTER III
MATERIALS AND METHODS

A.

Tumor Cell Line.
The EL-4 lymphoma (40) was obtained from R.

Herberman, National Cancer Institute, Bethesda,
Maryland.

EL-4 cells were maintained in vitro in

corning 25 cm2 tissue culture flasks

(Corning, NY)

containing RPMI 1640 (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (low LPS)
(Gibco, Grand Island, NY) penicillin 100 units/ml,
streptomycin 100 µg/ml, and Fungizone (PSF) (Whittaker,
Walkersville, MD) 0.25 µg/ml, and 2mM L-glutamine
(Gibco, Grand Island, NY).

Cells were passaged

3

times

weekly with maximal concentration not exceeding l x
106/ml.
B.

Radiolabelling of EL-4 Tumor Cells.
Tumor cells maintained in vitro were

washed once

in culture medium and resuspended to 2 to 5 x 106
cells/ml.

The cells were subjected to centrifugation at

soo x g for 10 min, decanted, and the pellet resuspended
in approximately 0.1 ml of culture medium.

Then 100

µCi/ml of Na 2 5lcro 4 (New England Nuclear, Boston,
MA) was added to approximately 1 x 10 7 cells in a final
40
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volume of 0.2 ml.

These cells were incubated at 37°c

with 5% co 2 for 1 h with frequent agitation (every 10
min).

The cells were then washed four times in HBSS,

resuspended to 1 x 106 cells/ml in culture medium and
0.01 ml aliquoted to each well of a 96 well assay plate
(Falcon 3072, Oxnard, CA) {27,129).

c.

Fungal Culture
Candida albicans

ATCC 58716 obtained from T.

Hashimoto, (Loyola University Medical Center, Maywood,
IL) was used throughout this investigation.

Cultures

were stored at 25°c on Sabouraud Dextrose Agar (SDA)
(Becton Dickinson and Co., Cockeysville, MD).

Cells

used for experimentation were cultured overnight at 37oc
on SDA, collected as isolated colonies, and washed once
in HBSS prior to inoculation into Dulbecco's modified
Eagle medium {DMEM, 4.5 g/L glucose) {Whittaker,
Walkersville, MD).

Any culture with greater than 15%

budding cells was discarded.

Candida hyphal forms were

obtained by incubation at 37°c in DMEM.

The inoculum of

1 x 105 Candida yeast cells/ml yielded approximately
100% hyphal fragments ranging in length from 40-65 µm
when incubated for 3 hat 37°c {46).
D.

Preparation of Macrophage Elicitation Agents.
Proteose peptone broth No. 3 {Difeo Laboratories,

Inc., Detroit, MI) was prepared as a 10% sterile
solution. Aliquots were placed in 5 ml batches and
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frozen at -20°c until needed.

Brewer Thioglycollate

Medium (Difeo Laboratories, Inc., Detroit, MI) used for
intraperitoneal injections of mice was prepared as
described previously (16,74).

An autoclaved solution

was allowed to become oxidized for six months in storage
at room temperature.

The media was distributed in 5 ml

aliquots and frozen at -20°c for later use.
E.

LPS Preparation.
LPS from Salmonella typhosa 0901 was purchased

from Difeo Laboratories, Inc., (Detroit, MI), in
lyophilized form.

After rehydration, the LPS was

distributed into 1 ml aliquots at a concentration of 500
µg/ml and stored frozen at -20°c until needed (16).
F.

Macrophages
Female C57Bl/6 mice (Jackson Labs, Bar Harbor,

ME), 8-16 weeks of age, were injected intraperitoneally
with 1 ml of freshly prepared proteose peptone broth or
1 ml of aged thioglycollate broth.

After 4 days, the

mice were sacrificed by cervical dislocation and the
peritoneal exudate cells (PECs) removed by lavage with
10 ml of HBSS (74).

The PECs were also removed from

normal mice which were not injected with proteose
peptone or thioglycollate.

The PECs were washed twice

in HBSS and resuspended in RPMI-1640, supplemented with
10% FBS, (Gibco, Grand Island, NY), penicillin 100
µg/ml, streptomycin (Whittaker, Walkersville, MD) 100
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ug/ml, and 2mM L-glutamine (Gibco, Grand Island, NY).
Fungizone was omitted from the medium.

These PECs were

then allowed to adhere as described below to plastic
culture vessels, either 24 or 96 well plates (Falcon
3047 or 3072, Oxnard CA).

The non-adherent cells were

removed by withdrawing the medium and gently flushing
once with fresh culture medium which was immediately
removed.

Viability was routinely determined by 0.04%

trypan blue exclusion.
G.

Macrophage Activation.
The groups of macrophages evaluated by this study

were; I= Resident, II= Induced, III= Activated, and IV=
Post-Activated (82).

Group I macrophages were obtained

from the peritoneal cavity of naive mice (27).

Mice for

groups II - IV were injected four days previously with
10% proteose peptone broth.

Group II were proteose

peptone-induced macrophages with no in vitro treatment.
Group III were macrophages activated in vitro with LPS
(10 µg/ml) for 18 h.

Group IV were macrophages which

were cultured in vitro with LPS (10 µg/ml) for 72 h.
Mice injected with thioglycollate broth four days
previously were termed group IIt-IVt and were treated as
described above for proteose peptone-elicited macrophage
states II-IV.

Additionally, some group I macrophages

were treated in vitro with LPS (10 µg/ml) for either 18
h or 72 h and were termed group IIIr or group IVr,
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respectively.
H.

Tumor Cytotoxicity Assay.
The methods employed for this assay are modifi-

cations of the procedure originally described by Doe and
Hansen (16,27).

PECs used for tumor cytotoxicity assays

were placed in 96-well plates (Falcon 3072, Oxnard, CA)
at 2 x 105 PECs/well.

Two h later the non-adherent

cells were removed by aspiration of the media and
replacement with fresh culture medium (0.2 ml).

The

wells were approximately 70-80% confluent with macrophages for all groups. Following an additional 20-24 h
of incubation at 37°c, nonadherent cells were removed
and fresh medium added.

These adherent PECs are

referred to as macrophages. At this time, LPS was added
in a final concentration of 10 µg/ml to each well for
groups III and IV.

After 18 h of incubation for groups

I-III and 72 h of incubation for group IV, 1 x 104
labelled tumor cells were added to each well in a 0.01
ml volume.

Following an additional 18-24 h, the plates

were subjected to centrifugation for 5 min at 200 x g,
100 µl of the supernatant fluid was removed from the 0.2
ml volume contained in each well, and assessed for
radioactivity by use of an automated gamma counter
{Beckman, Gamma 4000, Irving, CA).

Maximum release was

obtained by adding 0.5% Nonident P-40 {Sigma Chemical
Co., St. Louis, MO) to wells containing media and
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macrophages without LPS.
Data for this assay was based on a 20:1 effector/target
ratio and results are expressed as % cytotoxicity as
judged by release of Slcr.
% cytotoxicity

=

(mean experimental DPM) - Cmean minimum DPM)
(mean maximum DPM)

xlOO.

- (mean minimum DPM)

Results are expressed as the mean of triplicate cultures
from four separate experiments.
I.

Candida Cytotoxicity Assay.
Candidacidal activity of macrophages was quant-

ified by the microcolony method of Hashimoto (46).

This

method takes advantage of the dimorphic nature of
Candida.

PECs were placed in 24-well plates (Falcon

3047, Oxnard, CA) at 1 x io6 cells/well, with a 12 mm
circular cover slip (no. 1: Rochester Scientific co.
Inc., Rochester, NY) within each well.

PECs were

treated and activated as described above for the
tumoricidal assay except, that culture medium was
removed.and the macrophages gently washed to remove
fungizone prior to the addition of Candida in DMEM.
viability of individual

~.

The

albicans hyphae recovered

from the culture wells was determined as follows:

non-

phagocytosable Candida hyphae were exposed to macrophages at an effector/target ratio of 10:1, and incubated on the surface of cover glasses placed in the
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bottom of a well of a 24 well cluster plate for 1 h.
The DMEM was removed.

Sabauroud's dextrose broth

containing 0.5% Nonident P-40 (Sigma Co. St. Louis,
MO) was added to each of the wells. The cover slips were
recovered from the wells, gently rinsed in Sabauroud's
dextrose broth without Nonident P-40, and placed
inverted on a slide containing a thin layer of SDA (10
mm thick).

This procedure only partially lyses the

macrophage membrane allowing essentially all of the
Candida hyphae to adhere to the glass surface via
remnants of the macrophage membrane.

The microculture

was incubated under conditions conducive to the yeast
phase of growth at 37°c for 5 h in a moist chamber.

The

cultures were examined with a phase contrast microscope.

Routinely, 200 hyphae were examined for each

sample, and the percentage of nonviable hyphae in each
sample calculated.

Results are expressed as the mean of

triplicate cultures and four separate experiments.
J.

Statistics
The Student's t test was used to determine the

statistical significance of results.

CHAPTER IV
RESULTS
Four different groups of macrophages were
compared for their tumoricidal and candidacidal activities.

Results which compare the tumoricidal activity of

the four groups of macrophages are presented in Fig. 1.
Compared to group I

(resident macrophages), a signifi-

cant increase in cytotoxic activity was observed for
groups II (macrophages elicited from the peritoneal
cavity with protease peptone) and I I I (proteose peptoneelicited macrophages activated in vitro with LPS (10
µg/ml) for 18 h), while a significant decrease was
observed for group IV (protease peptone-elicited
macrophagess incubated in vitro for 72 h with LPS (10
µg/rnl).

The cytotoxic activity of group

at 40.5% ± 0.7%
45.2% ± 0.6%

I

macrophages

release was exceeded by group I I at

release (p<0.001).

greatest tumoricidal activity at

Group I I I showed the
53.8% ± 1.5%

release

(p<0.001) when compared to group I. However, macrophages
stimulated with LPS for 72 h (group IV) showed a
significant decrease (p<0.001) in cytotoxic activity to
29.7% ± 0.7%, when compared to group I macrophages.

A

significant increase (p<0.001) in cytotoxic activity was
observed between group III (53.8% ± 1.5%
group I I (45.2% ± 0.6%

release).
47

release) and

There was no signifi-
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Figure 1.
comparison of macrophage groups as judged by 18 h 5lcr
release assay. Values are displayed as mean of 4
experiments performed in triplicate.
Bars indicate ±
standard deviation (SD). Macrophage populations are
as follows; group I (resident macrophages), group II
(proteose peptone-elicited macrophages), group III
and group IV were proteose peptone-elicited and either
treated with LPS for 18 h (group III), or treated with
LPS for 72 h (group IV). Groups II and III are
significantly (p<0.001) higher than group I, while
group IV is significantly (p<0.001) lower than group
I. Group II is significantly lower than group III
(p<O. 001).
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cant difference in cytotoxicity between group I resident
macrophages cultured for 72 h without LPS stimulation
and group I (data not shown).
As a comparison, macrophages from group I were
exposed to LPS (10 µg/ml) in vitro for 18 h or 72 h.
See Table 2.

These macrophage groups were termed group

III resident (IIIr) and group IV resident (IVr),
respectivly.

Cytotoxixicty by macrophages from group

IIIr (54.8% ± 1.7%

release) was not significantly

different in tumoricidal activity from the experimental
group III (53.8% ± 1.5 % release).

Group IIIr was

significantly more cytotoxic than either group II
(p<0.001) or group I (p<0.001).

Group IVr (31.3% ±

1.8%) displayed a significantly lower level of cytotoxic
activity then group I while displaying no difference
with regard to group IV.
In an identical series of experiments, macrophages
were thioglycollate-elicited (group IIt), or thioglycollate-elicited and treated with either LPS (10 µg/ml) for
18 h (group IIIt), or LPS (10 µg/ml) for 72 h (group
IVt).

Tumoricidal activity of the group IIt macrophages

(51.7% ± 1.7%

release) showed a

significant increase

(p < 0.001) from both group I (40.5% ± 0.7%
and group II (45.2% ± 0.6%

release). There was no

difference between group IIt and group III.
showed a

release)

Group IIIt

significant increase from group III (p<0.05)
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Table 2.

Comparison of treatment groups as judged
by the extracellular tumoricidal assay.
Cytotoxicity
Eliciting Agent

Group
Number
I
II

Resident

Proteose
Pe pt one

None
(r)a

Thioglycollate
(t)b

40.5±o.7c
_d

51. 7±1. 7

45.2±0.6

III

53. 8±1. 5

54. 8±1. 7

57.6±1.9

IV

29.7±0.7

31.3±1.8

25.5±2.2

aResident macrophages (r) activated with LPS.
bThioglycollate (t)-elicited macrophages.
Coata expressed as the mean of 4 experiments performed
in triplicate ± SD. Groups II-IV (including all
resident activated; IIIr and IVr, and thioglycollate;
IIt, IIIt, and IVt) displayed a significance of
p < 0.001 when compared to group I. Additionally,
groups IIt, III, IIIt, and IIIr displayed a significant
increase (p< 0.001) to group II.
dExperimental values not determined due to protocol.
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producing the highest level of cytotoxicity.

Group IVt

macrophages (25.5% ± 2.2% release) showed a significantly lower (p<0.001) level of tumoricidal activity as
compared to those in group I. Additionally, group IVt
(25.5% ± 2.2%

release) was significantly (p<0.05) less

cytotoxic than both normal group IV (29.7% ± 0.7%
release) and resident group IVr (31.3% ± 1.8%

release).

Simultaneously, candidacidal activity was measured
with identical macrophage populations.

Results are

expressed as % cytotoxicity, defined as that part of the
culture able to return to the yeast

phase from the

hyphal phase following a 1 h exposure to the macrophage
populations. These studies showed that the level of
candidacidal activity paralleled that of the tumoricidal
assay.

See Figure 2.

The data show group I macrophage

activity which resulted in
22.2% ± 3.0%.

Candida cytotoxicity of

This differed significantly from the

34.5% ± 2.9% cytotoxicity observed following exposure to
group II macrophages (p<0.001). Treatment with LPS for
18 h (group III), significantly increased the candidacidal activity of these macrophages to 46.0% ± 3.9%
cytotoxicity (p<0.001).

Group II macrophages resulted

in Candida cytotoxicity of 34.5% ± 2.9% which was
significantly lower (p<0.001) than the cytotoxicity
(46.0% ± 3.9%} observed with group III macrophages.
However, unlike the tumoricidal results, there was no
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Figure 2.
Comparison of macrophage groups as judged by the
extracellular
candidacidal
assay.
Values
are
displayed as mean of 4 experiments in triplicate.
Bars indicate ± SD.
Groups are described in the
legend to Figure l.
Results are expressed as %
cytotoxici ty for Candida after l h exposure to the
various macrophage populations (* = p < 0.001 to group
I,+= p < 0.001 to group II).
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statistical difference between the cytotoxicity resulting after treatment with either group I or group IV
macrophages.
No appreciable differences were found between
macrophage candidacidal activity of either group IIIr
and group IVr or group III and group IV, respectively
(Table 3).

In the candidacidal assay, group IIt

macrophages produced a much higher cytotoxicity (43.2% ±
3.2%, p<0.001) when compared to group I macrophages
(22.2% ± 3.0%).

The cytotoxicity resulting after

incubation with group IIt macrophages was significantly
higher than that with group IIIt macrophages (47.1% ±
2.7%, p < 0.001).

However, no difference in cytotoxi-

city following exposure to macrophages of group IIt
(43.2% ± 3.2%) and group III (46.0% ± 3.9%) or group
IIIr (40.2% ± 4.2%) was observed.

56

Table 3.

Comparison of treatment groups as judged
by the extracellular candidacidal assay.
Cytotoxicity
Eliciting Agent

Group
Number
I
II

Resident

22.2±3.0 b
_j

Proteose
Peptone

None
(r)a

Thioglycollate
(t)

43.2±3.2d,i

34.5±2.9d

III

46.0±3.9d,i

40.2±4.2d,g

47.1±2,7d,i

IV

24.5±5.2e,h

17.7±2.7e,i

27.0±3,7c,f

aResident macrophages activated with LPS.
of Table 2 for abbreviations.

See footnotes

boata expressed as the mean of 4 experiments perf.ormed in
triplicate ± SD. Following notations denote significant
differences from stage I
c = p < 0.05 to stage I
d = p < 0.001 to stage I
e = p > 0.05 N.S.
Following notations denote significant differences from
stage II
f = p < 0.05 to stage II
g = p < 0.02 to stage II
h = p < 0.005 to stage II
i = p < 0.001 to stage II
jExperimental values not determined due to protocol.

CHAPTER V

DISCUSSION

It has been speculated that the mechanisms of
extracellular, non-specific, macrophage-mediated cytotoxicity are the same for any target (59).

The results

of this investigation indicate that the extracellular
cytotoxic activity of macrophages for two distinctly
different targets appears to be similar and to be
coincidentally expressed.

Parallel levels of extra-

cellular macrophage cytotoxicity for both schistosomula
and tumor cells have been demonstrated previously (67).
The cytotoxicity was found to be coincident regardless
of the method of macrophage treatment (59,67).

In

contrast, it has been noted that despite common mechanisms of macrophage induction and expression, the
observed macrophage effector functions may be variable
(88).

Killing of the yeast form of

~.

albicans by

peritoneal exudate cells, does not correlate with tumor
cytotoxic activity (13).

Other comparisons of activated

macrophages have shown that extracellular tumoricidal
activity did not correlate with intracellular candidacidal activity (114).

Macrophage activating factors
57
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which induced macrophage extracellular tumoricidal and
schistosomulicidal activity have been shown to differ
from

factors which induce intracellular microbicidal

activity (89).
The results of this investigation show that the
capabilities of resident (group I), proteose peptoneelicited (group II), proteose peptone-elicited and LPS
activated for 18 h (group III), and proteose peptoneelicited and LPS activated for 72 h (group IV) macrophages to be cytotoxic to Candida albicans paralleled
their capacity to be cytotoxic to a cultured cell line,
the EL-4 thymoma.
Resident

macrophages placed in culture for 18 h

were found to possess both extracellular fungicidal and
tumoricidal activity.

Previously published work has

shown resident macrophage populations to be at a basal
level of activation (82,128).

In those experiments,

resident macrophages were defined as cells derived from
the peritoneal cavity of mice and immediately employed
for cytotoxic activity against an extracellular target
(128).

In contrast, in this investigation macrophages

were cultured for 18 h prior to assessment of macrophage
predicted cytotoxicity.

Under these conditions,

resident macrophages do have the ability to kill both
fungi and tumor cells in an extracellular manner.
Likewise, the tumoricidal assay showed levels of
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resident macrophage activity which were higher than that
which has been reported previously (105).

This may be

attributed to variations in target type, mouse strain,
macrophage concentration, or the LPS employed.

However,

it is more probable that the relative activity of the
macrophages cultured for 18 h prior to onset of the
activation process have an enhanced cytotoxic activity.
During the 18 h culture period, macrophages were
adherent to plastic culture vessels and possibly exposed
to small amounts of contaminating LPS contained within
the serum of the media. Weinberg has shown LPS contamination of media culture products leads to a more
activated macrophage state (128).

Therefore, the

definition of resident macrophages in this study does
not necessarily equate with macrophage populations
termed "resident" in other studies (27,105).

The 18 h

period of incubation was necessitated by the experimental design in that a simultaneous time course for all
experiments was vital for comparative purposes.
l.n vitro, resident macrophages may be induced to

the activated state by simulating conditions in vivo.
For example, resident macrophages may be primed by an
antigenic stimulus resulting in the release of lymphokines.

such a stimulus could serve as an eliciting

agent, which has been reported previously to produce
enhanced cytocidal effects (54).

Macrophages induced by
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sterile irritants have been shown to be potentially
capable of cytolytic activity, if noncytolytic but
"receptive" monocytes were present (103).

Proteose

peptone-elicited macrophages (group II) from both the
tumoricidal and fungicidal assays displayed a parallel
increase in the extracellular killing of both targets.
A significant increase such as the one demonstrated here
does not agree with previous work which has demonstrated
proteose-peptone elicited macrophages do not reach a
level of macrophage activation which results in microbicidal or tumoricidal activity (128).

In those investi-

gations, macrophages were removed from the peritoneum
and utilized immediately (128).

Macrophages used in

experiments here were allowed to remain in culture for
18 h prior to the activation required for group III
macrophages. Therefore, a total time of 36 h elapsed
prior to evaluation of cytocidal activity.

This

treatment was identical to treatment received by group I
or resident macrophages which also resulted in higher
than expected cytocidal activity.

Nevertheless, at a

level of p<0.001 parallel differences have been found in
each of the assays.

These results indicate an increased

cytocidal activity for the overall population of
cultured macrophages.
When macrophages were treated with LPS (lOµg/ml)
for 18 h (group III), maximum tumoricidal and fungicidal
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activity was found for both assays.

The parallel

increase in functional cytocidal activity was apparent.
This is consistent with previous reports which show that
LPS can induce cytotoxicity by macrophages which are
already partly activated to maximum activity without
lymphokines (16,128).

To become cytocidal, less

activated cells require large doses (lOµg/ml) of LPS
(16).

Unactivated (resident) cells have been found to

vary in this response (16).

However this study has

shown that resident macrophages do obtain cytocidal
activity when treated with large doses of LPS.

Group

III macrophages were also observed to show an enhanced
level of activity over group II macrophages in both
systems.

Again, these results suggest parallel levels

of fungicidal and tumoricidal activity by the macrophage
population.

The parallel increases in cytotoxic

activity suggest the cytocidal effect to be non-specific
in nature.

That is, the mechanisms employed appear to

be capable of lysing diverse targets.
The one observed difference in which the relative
tumoricidal and fungicidal activity did not parallel
each other, was with group IV macrophages.

It was

expected that macrophages which had been maximally
activated would return to a level of cytocidal activity
at or near the unactivated or resident macrophage (2).
Group IV macrophages did return to a level of fungicidal
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activity which was not significantly different from
resident or group I macrophages.

However, the tumor-

icidal activity of group IV macrophages dropped to a
level significantly below that of the resident macrophages.

This may be attributed to the length of the

tumoricidal Slcr release assay in that the macrophages
were exposed to 10 µg/ml of LPS for 96 h.

The respon-

sive capability of the macrophages may have been
overwhelmed by this continued stimulation.

This is

further supported by the observation that cultures of
group I and group II macrophages which were not activated with LPS, but were simply cultured for 72 h,
demonstrated a level of activity near group I for both
the tumoricidal and fungicidal assays.

The observation

of a reduction in cytocidal activity provides a possibility that the macrophage may be a self-regulating
population.

The cells may produce a signal which

operates in a manner similar to the process of activation.

This regulatory product may be an arachidonic

acid metabolite, such as prostaglandin E, which has been
shown to down-regulate macrophage functional capacity by
limiting expression of tumor cytolysis and
other macrophage capacities.

certain

The suppressive effect may

also be a result of tolerance to the original stimulatory signal.

Clearly, a reduced response was observed.

Whether the effect is a consequence of a metabolite
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blocking a terminally differentiated or tolerant cell or
simply a cell which has returned to its basal level of
activity remains to be demonstrated.

Nevertheless, both

assay systems displayed significant decreases in
cytotoxicity from groups II and III to group IV.

In

this respect parallel killing was observed for all four
groups of macrophages.
When activated with LPS, thioglycollate-elicited
macrophages displayed the highest levels of cytocidal
activity in both assays.

Thioglycollate-elicited

macrophages displayed, in both the tumoricidal and
fungicidal assays, an enhanced cytotoxic activity
greater than that of macrophages elicited with proteose
peptone.

Thioglycollate broth is often used as an

eliciting agent because it has the advantage of recruiting large numbers of cells to the site of inflammation
(117).

However, the microbicidal activity of these

macrophages is variable, indicating the macrophages may
not be totally activated (85).

In contrast to previous

studies which place thioglycollate-elicited macrophages
into a functionally resident or primed classification
(54,74), experimental evidence here indicates that
thioglycollate-elicited macrophages may be in an
activated state. There was no difference between these
macrophages and protease peptone-elicited macrophages
activated with LPS.

These results may be the conse-
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quence of enhanced activation in vivo or as in the case
of group I and group II macrophages, a higher level of
activity induced during the activation period in vitro.

Miake has proposed that functional activities of
macrophage populations vary dependent upon the elicitation agent employed (85).

Miake further stated that

macrophage populations may have different levels of
cytocidal activity or activation.

The results of this

study have shown similar variability.

Proteose peptone

and thioglycollate broth both elicited macrophage
populations

which displayed significantly different

tumoricidal and candidalcidal activity.

Upon activation

with LPS both of these populations displayed levels of
activation which differed, indicating that levels of
activation are dependent upon the elicitating agent and
the activation signal.
Variable cytocidal activities have been reported
for thioglycollate-elicited macrophages (16,61,90).
Russell has shown that thioglycollate-elicited macrophages exposed to pg/ml concentrations of LPS will
activate macrophages for tumoricidal activity, which is
consistent with the study performed herein (105).
Additionally, Russell has shown that thioglycollateelicited macrophages do possess tumoricidal activity
without stimulation of LPS. Other groups have

reported
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different findings (27,49).

Any number of factors may

contribute to this discrepancy.

It has been proposed

that enhanced macrophage cytocidal activity of thioglycollate-elicited macrophages may be the result of
macrophage activation due to LPS-contamination (105).
Additionally, the cytocidal response of thioglycollateelicited macrophages has been shown to vary depending on
the particular batch of thioglycollate utilized.
Campbell (16) has demonstrated that Brewer's thioglycollate medium which was allowed to oxidize, produced
macrophages which had enhanced cytocidal activity when
cultured with LPS.

The thioglycollate used in these

experiments was allowed to oxidize for at least 6 months
at room temperature prior to elicitation process.
Many other points of variability exist when
considering elicitation with thioglycollate, including
the observation that varying levels of LPS concentrations have also been shown to be required for activation
of these cells to a cytocidal state (16).

However,

the high levels of LPS utilized in this study should
allow for maximum activation.

The age of the mouse may

also vary the activation level of thioglycollateelicited macrophages.

Hopper has shown no difference in

the number of macrophages elicited from the peritoneum
of mice from various eliciting agents at 6-8 week (54).
However, older mice display a different pattern of·
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macrophage inflammation and activity, thus displaying
more variability.

Therefore, variations in the ages of

mice employed in previous studies may have resulted in
variable cytocidal effects (54).
Bone marrow-derived macrophages have been described
as a precursor cell which matures through the monocyte
maturation pathway to become a fully functional macrophage (127).

Previous investigators have shown bone

marrow-derived macrophages,
tumoricidal (127).

upon activation, become

If bone marrow-derived macrophages

are driven to maturation prior to establishment of a
resident state, they possess a variety of extracellular
cytocidal activities against such targets as the yeast
form of both Candida, Cryptococcus, Leishmania, and
tumor cells (10).
It was the purpose of this investigation to
evaluate the maturation sequence of bone marrow-derived
macrophages after two weeks of in vitro cell culture.
Macrophages which were allowed to remain in culture
without the addition of LPS displayed levels of candidacidal activity which were not significantly different
from resident macrophages.

The candidacidal activity

was slightly higher, and could result from the length of
culture required to achieve maturation.
Identically treated bone marrow-derived macrophages
were pulsed with 10 µg/ml of LPS 18 h prior to evalu-
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ation of candidacidal activity.

This group of macro-

phages obtained levels of activity similar to that of
group II macrophages.

There were significant differ-

ences between these macrophages and peritonital macrophages activated with LPS.

It is possible that the bone

marrow-derived macrophages activated with LPS are in a
state of activation either between groups II and III or
between groups III and IV.

The 18 h activation period

employed may have been inadequate and henceforth, would
not allow sufficient time for proper activation to full
cytotoxicity.

Alternatively, LPS stimulation may have

been either too strong or too delayed following stimulation.

Either of these would result in the downregu-

lation of function and place the macrophages into a
level of cytocidal activity between groups III and IV.
The tumoricidal activity of the macrophage groups
correlate with previous attempts to define discrete
stages of macrophage activation.

The terminology of

resident, primed, and activated have been used to
describe levels of activation with regard to tumoricidal
activity (43).

The methodology and treatment of the

macrophages in these experiments was similar to the
procedure employed in this investigation.

Other stages

of activation have been proposed, such as inflammatory
(60) and responsive (61).

However, these stages are

difficult to evaluate because they are activated with
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lymphokines and furthermore they are defined by appearance of certain receptors such as C3 and 5'-nucleotidase
(61).

These stages may indeed be apparent.

However,

the comparison of functional cytocidal activity versus
the appearance of cellular maturation markers has not
been made.
The regulation process of macrophage activation for
functional activity is complex.

Comparisons of func-

tional activities must consider various aspects of the
assays used to measure functions including: the origin
of the responding cell, the activation signal, the
susceptibility of the target to the macrophage, and
nuances associated with the assessment of macrophage
function (81).
addressed.

In this study these parameters have been

An inbred strain of mouse was used to obtain

the groups of macrophages.

The macrophages were treated

in an identical manner from elicitation through lavage
to activation, both throughout the study and within each
experiment.

The macrophages were treated together until

separated for the assays, at which point treatments
received were identical.

The same level of LPS was

employed for all experiments (lOµg/ml).

This was based

on work by Weinburger which showed LPS at 10 µg/ml to be
effective in activating macrophages to tumoricidal
activity.

Additionally, in vitro experiments have shown

LPS to stimulate macrophages to kill Candida at lOµg/ml
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(98).

Furthermore, both targets have been shown

previously to be susceptible to the cytotoxic effects of
macrophages.
Other considerations must be made regarding these
assays such as the nature and concentrations of both the
target and effector cells.

Adherent peritoneal exudate

cells have been defined in this study as macrophages.
This definition implies only that non-adherent cells
were removed from the culture and does not absolutely
exclude the possibility that a small number of residual
non-adherent cells may remain which either directly or
indirectly influence the cytotoxic response of the
macrophages.

Campbell has shown that PECs were equally

cytotoxic whether removed by simple washing techniques
such as those employed herein, or by multiple vigorous
washings.

Additionally, if excess non-adherent spleen

cells were added to the culture wells, no increase in
cytotoxicity was noted (16).

Furthermore, macrophages

must be placed in culture, such that a less than
confluent monolayer of cells results (16,99).
important for two reasons.

This is

First, if the concentration

is too high, macrophages tend to round up and spread
poorly, resulting in inhibition of macrophage function.
Second, if the macrophages are too scarce in the culture
vessel, the cells fail to produce optimal cytocidal
activity.

This study utilized macrophage concentrations
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similar to those employed by Cambell for the tumoricidal
assay.

Likewise, the concentration of macrophages used

for the candidacidal assay was recommended by the author
of the assay to provide a monolayer (46).
While some of the problems associated with each
assay can be regulated, others cannot be as stringently
controlled.

For example, macrophage cytotoxicity assays

must take into account LPS contamination (99).

The

responsiveness to LPS appears to correlate with the
stage of macrophage functional differentiation, therefore, if macrophages with lower levels of functional
activity were exposed to contaminating doses of LPS they
may become further activated, as noted previously (127).
Further variations such as the stage of differentiation
and consequent functional responsiveness are parameters
not easily controlled, and are likely to be responsible
for variability among different systems (65).
A direct comparison of the data between the assays
must take into account the differences in the two
experimental systems.

One employs direct examination of

cytotoxicity while the other measures an index of
cytotoxicity as judged by the release of radioisotope.
The different methodologies involved with these assays
may account for the different range of data obtained.
Therefore, levels of activity between these assays
cannot be compared directly.

However, comparisons can

71

be made between groups within an experimental system and
comparisons can be made between relative changes in both
systems.

The results of these experiments, have shown

statistically that nearly parallel levels of extracellular cytocidal activity for fungi and tumor cells
exist.

The only exception was in post-cytolytic

activity where the tumoricidal capacity of the macrophages dropped to a level significantly lower than group
I.

This was not the case for fungicidal activity which

returned to group I levels.

The observed difference may

relate to the total time required to accomplish the two
assays; measurement of fungicidal activity was 73 h in
duration, while measurement of tumoricidal activity
required a total of 96 h.

Likewise, the difference in

culture time and the difference in actual assay time may
contribute to the varied results, but has not been
explored.

Macrophages possess numerous physiological

properties that may be modulated during the activation
process.

An expression of one such function, extracel-

lular cytocidal ability, may be related in some form to
other macrophage functions.

However, the parallel

levels of cytocidal activity suggest that extracellular
killing is the same for all macrophage groups employed
in this investigation.
The mechanism by which macrophages recognize and
lyse various targets is poorly understood (2).

However,
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it is possible to speculate on a mechanism of killing by
which the macrophages employed within this study lyse
two diverse targets.

The concept of the nonspecific

response of macrophages originally proposed by Mackannas
(77), does not explain or demonstrate how a macrophage
recognizes, binds tq, and destroys targets
as foreign.

recognized

The data obtained by many investigators

off er a variety of theories regarding this matter
(2,60,130).

However, the data obtained in this study

supports the.concept of similar interactive and functional activities, regardless of the nature of the
target.
Complex cytocidal mechanisms for macrophagemediated destruction for a diverse set of target cells
has been described (6).

Each of a multitude of toxic

substances has been proposed as the effector molecule
for cytotoxic activity including; proteases, C3a,
arginase, H2o 2 , TNF, and cytotoxins.

The primary

reaction of macrophage activation could result in
increased synthesis of factors mediating the cytotoxic
activity (88).

Alternatively, precursor formation, or

accessory system development could assist in cytocidal
activities (88).

Macrophages could release these

effector or precursor molecules, resulting in lysis
various targets.
The process of macrophage cytotoxicity is normally
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considered to be cell-contact dependent.

Therefore,

upon recognition and binding of the target cell, a small
surface area of intimate contact would be established
(3).

Such surface contact could trigger a series of

metabolic events which allow the macrophage to secrete a
vast array of cytotoxic compounds (5).

These compounds

would be localized between the macrophage and its
target.

The area of macrophage-target surface contact

has been speculated to be protected from these compounds
(3).

Likewise, the effector molecules would be pro-

tected, both from dilution in the extracellular milieu,
and from degradation by extracellular proteases or
inhibitors (5).

Under some conditions, the macrophage

may not be protected from this concentrated assortment
of toxic metabolites and several studies have shown
deleterious effects of secretion products on macrophage
membranes invoked during the course of target cell
destruction (33).
Binding of targets to receptors on the macrophage
is thought to serve several functions in cytolysis
(119).

Two types of tumor cell binding exist; low level

and high level.

Low level-binding is a nonselective

attachment between many cell pairs while high levelbinding allows only selective binding between tumor
cells and activated macrophages (60).

It is possible

for macrophages to convert a weak nonselective binding
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to stable binding if tight binding between macrophage
and target cell occurs (113).
Macrophages selectively bind tumor cells with
specific cell markers to their surface. The biochemical
determinants of the macrophage tumor cell receptor are
unknown except for the participation of a trypsinsensi ti ve cell-binding site which is very similar to a
receptor (113).

However, unlike normal receptor-ligand

interaction, energy is required to bind the tumor cell.
Certain tumor cells have adapted their markers in such a
way as to be resistant to recognition by certain cell
types in certain strains of animals (2).
Macrophages also possess receptors which recognize
nonphosphorolated, terminal mannose, N-acetylglucosamine
and fucose residues (24).

Such a recognition mechanism

provides a means for microbial binding prior to phagocytosis (11). The blockage of this calcium dependent
receptor inhibits the binding of mannose by macrophages,
indicating a specificity for mannose (119).

This

specificity is not enhanced or decreased by level of
macrophage activation.

Furthermore this mannose

specific receptor diminishes in latter stages of
activation (57).
Different effector molecules may exist for different targets.

The secretion of the multitude of

cytocidal substances allows both for the specific
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killing of targets by one mechanism and also for
molecular synergism, resulting in enhanced cytocidal
activity.

For instance, specific mechanisms such as ROI

have proven very effective against Candida while
nonoxidative mechanisms seem only to mediate partial
cytocidal effects (26).

Conversely, secreted products

such as TNF and cytotoxic factors have proven effective
against tumor cells, while oxidative mechanism for
tumoricidal activity are equivocal (91).

Oxidative and

non-oxidative means of cytocidal activity have been
shown to cooperate in tumoricidal systems.

H2 o 2 and

cytotoxins combine for greater tumoricidal effect than
either produces separately (60).
The expression of nonspecific effector activities
by macrophages differ with the nature of the target and
its relationship to the macrophage.

The activation for

extracellular versus intracellular effector activity
share many common characteristics but can ultimately be
dissociated on the basis of the target, the responding
cell, and inductive signal.

The details of each

effector function of activated macrophages are unique
for each target and has been shown to be dependent upon
the lymphokine which activates the macrophage (88).
Therefore at one level, regulation may not be dictated
by the target, but by the site, either intracellular or
extracellular (88). For example, the alteration of
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membranes associated with phagocytosis may regulate the
cell and initiate intracellular killing mechanisms (96).
It can be speculated that lymphokines which induce
intracellular killing provide the same type of activating signal to the macrophage as that of phagocytosis.
The regulation of extracellular killing is much
more complex.

Maximum antimicrobial activities against

intracellular organisms is induced within 4 h regardless
of the sequence in which the target, macrophage, and
signal are presented. However, maximal extracellular
killing requires the presence of macrophage, target and
activation signal at the same time (88).

Furthermore,

any ingested cell could be killed by a combination of
cytotoxic products concentrated within the phagosome.
However, due to the nature of the killing process, the
macrophage must recognize which extracellular cytocidal
mechanism to induce for effective killing of a nonphagosotized organism.
Evaluation of the extracellular killing mechanism
employed in this study proves difficult for the following reason.

The ability of the macrophage to kill

two distinct targets, a single eukaryotic cell compared
to a multiseptated hyphae implies utilization of
different effector mechanisms.

This is due to the

variable susceptibility of fungal wall polymers of
mannose as compared to the simple phospholipid bilayer
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associated with tumor cells.
These mechanisms may be regulated at two different
levels.

At the first level, the cell activates either

intracellular or extracellular mechanisms of cytocidal
activity.

Destruction of two different extracellular

targets may be induced by the same cytolytic mechanisms,
which are activated by signals which trigger extracellular killing mechanisms.

Conversely, intracellular

cytolytic activity would be activated by signals which
would induce intracellular killing.
The secondary level is more complex.
noted that several possibilities exist.

It must be
First of all

macrophages may recognize target cells by binding to
them as a result of certain receptors (i.e. mannose)
present on macrophages.

This binding may then activate

a particular cascade of products which could allow the
macrophage to respond in an appropriate and specific
manner to a stimulus.

Secondly, all products of the

cytotoxic potential may be released to the extracellular
environment.

The regulation of this release would be

time dependent. Therefore, only at various time points
in the maturation process would certain effector
molecules be released.

This may limit specific killing

of targets yet would allow for nonspecific killing,
albeit at various time points.
Finally, functional subsets of macrophages which

78

were present upon maturation to macrophages would be
activated against a specific target.

These cells would

be activated to mediate specific cytocidal effector
mechanisms against specific predefined targets.
Data from this study which shows parallel levels of
cytocidal activity in four different groups of macrophages, against these two targets does not support the
last possibility, that functional subsets exist.
However, many investigators favor this explanation
(22,96,127).

Meltzer has proposed that all cytocidal mechanisms
are enhanced first intracellular, then extracellular
microbicidal activity, followed by tumoricidal activity
(80).

This study does not refute this concept, since

the variance in time frames which may be required to
observe this method of cytocidal activity utilized may
not have been studied.

However, in the context of this

study, sequential effector function must be questioned
since parallel increases and decreases in cytocidal
activity were found with all groups of macrophages
analyzed.

Alternatively, extracellular killing for all

targets may be parallel.
It is entirely possible that macrophages, once
activated for extracellular cytocidal activity recognize
specific markers on target cells such as mannose or
tumor cell membrane markers.

Once bound the macrophage
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would then rechannel cytocidal activity to specific
mechanisms based on which receptors are bound.

It has

been shown that macrophages which are strongly tumoricidal and then challenged with schistosoma are only
weakly cytolytic (88).

While it is possible that

sequential levels of functional activity may be invoked,
experiments to assess specific recognition have not been
performed.

Other studies have shown that macrophages

activated for a particular tumoricidal response do show
levels of activity for other organisms, thus implying
that activity against these targets appears in a
secondary or nonspecific manner.
Finally, this study has demonstrated that macrophages at various levels of activation possess varying
levels of cytocidal activity.

However, it is known that

nonactivated macrophages possess higher levels of
mannose specific receptors.

Therefore, such macrophages

would bind more readily to Candida.

Once bound the

Candida may activate the macrophage directly through
binding, or indirectly through activation mechanisms
similar to those described for LPS and lymphokines.
The results obtained in this study emphasize many
of the problems encountered when studying macrophage
activation.

Grouping, elicitation, cell targets and

functional differences found in the different stages of
activation

all contribute to variability among results
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Any given population of cells may also vary due

to state of the host and dose of antigenic stimuli.
Therefore, during active infection or simulated conditions of active infection, a maximum stimulus for
macrophages occurs

(130).

Conditions of maximum

stimulation, would be the most opportune time to
comparitively study functional properties of macrophages.

It has been suggested that these properties may

occur and be lost at different rates within the population (130).

This renews the theory that separate

subpopulations of effector cells display activated
properties and could modulate the population as a whole
(126).

Despite the merits of this theory (130) the data

collected herein would contradict it, since parallel
functional levels of activity have been found in both
the candidacidal and tumoricidal systems at each level.
The only exception to this was macrophages incubated
with LPS for 72 hrs.

In this case the macrophages from

both assays did return to a level near that of the
resident macrophages.

The tumoricidal assay dropped to

a level even lower, probably due to reasons already
discussed.

Alternatively, the mechanism by which

macrophages produce their cytocidal effects may be
similar, which could explain in part the parallel
cytocidal activity (88).
A comparison of macrophage extracellular tumori-
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cidal activity, as judged by 51cr release assay, and
fungicidal activity, as judged by inhibition of Candida
albicans yeast formation following hyphal induction, has
resulted in a strong correlation of activity with four
separate macrophage treatment groups.

This correlation

indicates parallel levels of extracellular cytocidal
activity over a range of the macrophage maturation
groups and suggests similar mechanisms of extracellular
killing.

SUMMARY

This investigation compared the tumoricidal and candidacidal activity of four groups of murine macrophages.
Resident macrophages (Group I) displayed the least
cytocidal activity. Proteose peptone-elicited macrophages (Group II) showed a significant increase in
cytocidal activity over group I (p<0.001) in both
tumoricidal and fungicidal assays.

Proteose peptone-

elicited, 18 h LPS-treated macrophages (Group III)
displayed a significantly greater level of activity than
either group I (p<0.001) or group II (p<0.001) macrophages in both tumoricidal and fungicidal assays.
Proteose peptone-elicited, 72 h LPS-treated macrophages
(Group IV) showed a decrease in fungicidal activity to a
level near group I, while the tumoricidal activity
dropped to a level significantly below group I (p<0.001)
macrophages.

These data indicate a parallel relation-

ship between the killing, via extracellular mechanisms,
of both fungi and tumor cells by these four groups of
macrophages.
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